• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

    11/29/23 8:11:02 AM ET
    $ATNF
    $ATXI
    $AULT
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ATNF alert in real time by email

    Shares of Workday, Inc. (NASDAQ:WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter.

    Workday posted earnings of $1.56 per share, beating market estimates of $1.41 per share. Revenue of $1.87 billion topped the analyst consensus estimate of $1.848 billion.

    Workday anticipated fourth-quarter subscription revenue to be $6.598 billion while adjusted operating margins were estimated to be 23.8%.

    Piper Sandler maintained Workday with an Overweight and raised the price target from $275 to $300.

    Workday shares rose 9% to $258.70 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • 180 Life Sciences Corp. (NASDAQ:ATNF) shares rose 55.2% to $0.5230 in pre-market trading after gaining around 8% on Tuesday. 180 Life Sciences recently announced a review of strategic alternatives.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) shares rose 47.3% to $3.36 in pre-market trading after jumping 128% on Tuesday. Redhill Biopharma recently announced the FDA has granted five years' market exclusivity for Talicia.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) rose 39.4% to $0.2649 in pre-market trading. Avenue Therapeutics recently posted a profit for the third quarter.
    • Yoshiharu Global Co. (NASDAQ:YOSH) shares surged 26.1% to $6.04 in pre-market trading after gaining over 22% on Tuesday.
    • Ault Alliance, Inc. (NYSE:AULT) shares rose 24% to $0.1007 in pre-market trading. Ault Alliance Executive Chairman Milton C. Ault III acquired a total of 350,144 shares at an average price of $0.09.
    • Kelso Technologies Inc. (NYSE:KIQ) gained 23.4% to $0.2020 in pre-market trading. Kelso Technologies recently reported an increase in third-quarter sales.
    • Fluence Energy, Inc. (NASDAQ:FLNC) shares climbed 20% to $24.32 in pre-market trading after reporting fourth-quarter results. Fluence Energy also initiated FY24 revenue guidance of $2.7 billion to $3.3 billion.
    • Biomea Fusion, Inc. (NASDAQ:BMEA) shares gained 19.4% to $11.87 in pre-market trading.
    • GameStop Corp. (NYSE:GME) gained 15.3% to $15.55 in pre-market trading after gaining around 13% on Tuesday.

    Losers

    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) dipped 39.9% to $1.43 in pre-market trading after the company reported pricing of $5.55 million public offering.
    • Leslie's, Inc. (NASDAQ:LESL) shares fell 15% to $4.95 in pre-market trading after the company reported mixed fourth-quarter financial results.
    • ESGL Holdings Limited (NASDAQ:ESGL) fell 12.3% to $1.14 in pre-market after jumping 45% on Tuesday. ESGL recently announced a multi-year contract renewal with Singapore Refining Company Private Limited.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 12% to $1.03 in pre-market trading. SMX recently announced planned launch of world's first plastic cycle token.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) shares fell 11.2% to $10.60 in pre-market trading after the company reported pricing of public offering of common stock and concurrent private placement.
    • HNR Acquisition Corp (NASDAQ:HNRA) fell 10.7% to $3.25 in pre-market trading. HNR Acquisition shares jumped 110% on Tuesday after the company gave a business update.
    • Smart for Life, Inc. (NASDAQ:SMFL) shares fell 10.3% to $1.38 in pre-market trading. Smart For Life recently announced a 1-for-3 reverse stock split.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares fell 9.6% to $3.75 in pre-market trading. Biodexa Pharmaceuticals shares fell over 18% on Tuesday after the company announced an offering of 1,397,849 Class A units at an assumed public offering price of $2.79 per Class A unit.
    • Impel Pharmaceuticals Inc. (NASDAQ:IMPL) fell 9.4% to $0.5410 in pre-market trading.
    • Okta, Inc. (NASDAQ:OKTA) fell 7.3% to $67.29 in pre-market trading. Okta disclosed that a data breach has affected all users of its customer support system.

     

    Now Read This: Dollar Tree, Salesforce And 3 Stocks To Watch Heading Into Wednesday

    Get the next $ATNF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATNF
    $ATXI
    $AULT
    $BDRX

    CompanyDatePrice TargetRatingAnalyst
    Workday Inc.
    $WDAY
    2/23/2026$150.00Buy → Hold
    Jefferies
    Workday Inc.
    $WDAY
    2/18/2026Mkt Outperform → Mkt Perform
    Citizens
    Workday Inc.
    $WDAY
    2/17/2026$285.00 → $204.00Outperform
    BMO Capital Markets
    Fluence Energy Inc.
    $FLNC
    2/10/2026$24.00Hold → Buy
    Jefferies
    Leslie's Inc.
    $LESL
    1/15/2026$1.50Equal-Weight → Underweight
    Morgan Stanley
    Okta Inc.
    $OKTA
    1/14/2026$120.00Equal-Weight → Overweight
    Stephens
    Biomea Fusion Inc.
    $BMEA
    1/13/2026$8.00Buy
    Rodman & Renshaw
    Workday Inc.
    $WDAY
    1/12/2026$238.00Neutral
    Goldman
    More analyst ratings

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease

    ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to enzyme replacement therapy MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (OTC:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies for rare and neurologic diseases, today announced that it has entered into an exclusive worldwide license agreement with Duke University for patents and know-how pertaining to ATX-04 (clenbuterol), a well-characterized small-molecule β2-adrenergic agonist, in clinical development for the treatment of Pompe disease. Pompe d

    2/23/26 8:00:00 AM ET
    $ATXI
    $FBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    M2i Global, along with Volato Group, and SMX Execute Collaboration Agreement for Pilot Initiative to Enable Secure Tracking and Traceable Critical Minerals Commerce Through CAINO and the M2i Metals Marketplace

    Agreement is first step to advance critical minerals shipment assurance, digital chain-of-custody, and authenticated marketplace transactions Atlanta, GA and Reno, NV, Feb. 19, 2026 (GLOBE NEWSWIRE) -- M2i Global, Inc. ("M2i," the "Company," "we," "our" or "us") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, along with Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven company, is pleased to announce that it has entered into a Strategic Collaboration Agreement with SMX (Security Matters) PLC (NASDAQ:SMX) ("SMX"), a publicly traded company focused on supply chain traceability and integrity sol

    2/19/26 9:00:00 AM ET
    $SMX
    $SOAR
    Industrial Machinery/Components
    Technology
    Transportation Services
    Consumer Discretionary

    Biomea Fusion to Participate at Upcoming Investor Conferences

    SAN CARLOS, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ("Biomea" or "Company" or "Company management") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in the following upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences Conference: Biomea will present virtually on February 26, 2026, at 10:00 AM (EDT). Company management will also meet with investors in one-on-one meetings during the conference.The Citizens Life Sciences Conference: Biomea will present at 2:50 PM (EDT) on March 10, 2026, in Miami, FL. Company management will also meet with investors in one-on-one meetings during the confer

    2/19/26 7:00:00 AM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Accounting Officer Philpot Michelle

    4 - Fluence Energy, Inc. (0001868941) (Issuer)

    2/20/26 4:09:01 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by SVP & CCSO Zahurancik John

    4 - Fluence Energy, Inc. (0001868941) (Issuer)

    2/20/26 4:08:03 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by SVP, Chief Growth Officer Monday Jeffrey Richard

    4 - Fluence Energy, Inc. (0001868941) (Issuer)

    2/20/26 4:06:33 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $ATNF
    $ATXI
    $AULT
    $BDRX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TRUDHESA issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug TRUDHESA (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/13/21 2:21:35 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DIHYDROERGOTAMINE MESYLATE issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug DIHYDROERGOTAMINE MESYLATE (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/7/21 1:04:43 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Workday downgraded by Jefferies with a new price target

    Jefferies downgraded Workday from Buy to Hold and set a new price target of $150.00

    2/23/26 8:34:02 AM ET
    $WDAY
    EDP Services
    Technology

    Workday downgraded by Citizens

    Citizens downgraded Workday from Mkt Outperform to Mkt Perform

    2/18/26 7:53:34 AM ET
    $WDAY
    EDP Services
    Technology

    BMO Capital Markets reiterated coverage on Workday with a new price target

    BMO Capital Markets reiterated coverage of Workday with a rating of Outperform and set a new price target of $204.00 from $285.00 previously

    2/17/26 7:02:27 AM ET
    $WDAY
    EDP Services
    Technology

    $ATNF
    $ATXI
    $AULT
    $BDRX
    SEC Filings

    View All

    SEC Form 6-K filed by SMX (Security Matters) Public Limited Company

    6-K - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/23/26 5:00:03 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    Avenue Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - AVENUE THERAPEUTICS, INC. (0001644963) (Filer)

    2/23/26 4:06:15 PM ET
    $ATXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by SMX (Security Matters) Public Limited Company

    6-K - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/19/26 9:49:50 AM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Leadership Updates

    Live Leadership Updates

    View All

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials

    Workday to Invest CAD $1 Billion in Canada Over Five Years

    Investment to Fuel the Growth of Workday's Canadian Business and Support Workday's Rapidly Growing Canadian Customer Base Company Joins With Glowing Hearts Reservist Registry as Part of Ongoing Efforts to Support Local Communities in Canada PLEASANTON, Calif., Jan. 20, 2026 /PRNewswire/ -- Workday, Inc.  (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced its plans to invest CAD $1 billion in Canada over the next five years. The multi-year investment demonstrates Workday's commitment to growing in Canada, including plans to further develop local tech talent, strengthen local customer support, and give back to Canadian communities through particip

    1/20/26 8:00:00 AM ET
    $WDAY
    EDP Services
    Technology

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Financials

    Live finance-specific insights

    View All

    Leslie's, Inc. Announces First Quarter 2026 Financial Results

    Sales and adjusted EBITDA in-line with Company expectations, reiterates full year guide 80 underperforming stores closed during Q1 2026 Improved inventory efficiency with ~23% reduction year-over-year PHOENIX, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced its financial results for the fiscal first quarter 2026. Jason McDonell, Chief Executive Officer, said, "Leslie's transformation journey is gaining momentum as we execute with precision and urgency. Our first quarter results met our expectations,

    2/17/26 4:15:00 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    Fluence Energy, Inc. Reports First Quarter 2026 Results; Reaffirms Fiscal Year 2026 Guidance

    ARLINGTON, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ:FLNC) ("Fluence" or the "Company"), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months ended December 31, 2025. Financial Highlights for Fiscal Quarter ended December 31, 2025 Revenue of approximately $475.2 million, which represents an increase of approximately 154.4% from the same quarter last year.GAAP gross profit margin of approximately 4.9%, and adjusted gross profit margin1 of 5.6%. First quarter 2026 GAAP gross profit margin includes additional estimated costs on two projects, a majority o

    2/4/26 4:05:00 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Leslie's, Inc. to Report First Quarter 2026 Financial Results on February 17, 2026

    PHOENIX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced it will release its first quarter 2026 financial results after market close on Tuesday, February 17, 2026. The company will host a conference call at 5:00 p.m. Eastern time on February 17, 2026 to discuss the financial results as well as progress against the company's strategic transformation initiatives. A live webcast of the conference call will be available online at https://ir.lesliespool.com/. A replay of the conference call will be availab

    2/3/26 4:15:00 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    $ATNF
    $ATXI
    $AULT
    $BDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    12/4/24 1:29:12 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Biodexa Pharmaceuticals plc American Depositary Shs

    SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)

    11/20/24 11:56:39 AM ET
    $BDRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Verve Therapeutics Inc.

    SC 13G - Verve Therapeutics, Inc. (0001840574) (Subject)

    11/18/24 5:23:52 PM ET
    $VERV
    Biotechnology: Pharmaceutical Preparations
    Health Care